MSCI Inc. (0A8Y)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 614.99 |
|---|---|
| 52-week range | 500.00 – 655.00 |
| Return, 1 month / 3 months | +10.4% / +11.2% |
| Return, 1 year / 3 years | +15.7% / +29.4% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -17.1% |
| Average daily value traded | 0.41M USD |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MSCI Inc. is a provider of investment research and market data, based in New York. It builds and maintains equity indexes that institutional investors use as benchmarks, and it supplies risk models, portfolio analytics and governance tools to asset managers, banks, pension funds and other financial institutions. Its clients rely on these products to measure performance, assess exposure and manage portfolios across markets worldwide. The company also offers data and software services tied to environmental, social and governance factors.
MSCI Inc. trades under the code 0A8Y on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MSCI Inc. (0A8Y) trades on the London Exchange in UK. It last closed at USD 614.99 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,111 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.7% and over the last three months it rose 11.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.7% | ||
| From 52-week high | -3.4% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.2% | ||
| 6-month return | 5.3% | ||
| 12-month return, skipping the last month | 4.8% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.1% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.41M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.6% |
|---|---|
| 1 month | +10.4% |
| 3 months | +11.2% |
| 6 months | +5.3% |
| 1 year | +15.7% |
| 3 years | +29.4% |
| 5 years | +1.6% |
Signals
| 50-day / 200-day average | 562.52 / 571.02 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 22.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Aug 2026 | USD 2.0500 |
| 15 May 2026 | USD 2.0500 |
| 13 Feb 2026 | USD 2.0500 |
| 14 Nov 2025 | USD 1.8000 |
| 15 Aug 2025 | USD 1.8000 |
| 16 May 2025 | USD 1.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.